|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Mar 31, 2023
|
FY2021
12 months to Mar 31, 2022
|
FY2020
12 months to Mar 31, 2021
|
|
|---|---|---|---|---|---|
| Net Sales | |||||
| Cost of Sales | |||||
| Gross Loss | |||||
| Operating Expenses | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Depreciation | |||||
| Impairment of goodwill | |||||
| Total Operating Expenses | |||||
| Loss From Operations | |||||
| Other Expenses | |||||
| Gain from Employee Retension Credit Program refund | |||||
| Gain from settlement of accounts payable | |||||
| Loss from extinguishment of debt | |||||
| Interest expense | |||||
| Finance costs | |||||
| Total Other Income (Expense), net | |||||
| Change in fair value of warrant liability | |||||
| Loss on issuance of warrants | |||||
| Interest expense, net | |||||
| Total Other Expenses | |||||
| Loss From Continuing Operations Before Income Tax | |||||
| Income tax loss attributable to continuing operations | |||||
| Net Loss From Continuing Operations | |||||
| Net loss from discontinued operations | |||||
| Net Loss | |||||
| Net loss attributable to non-controlling interest | |||||
| Net Loss Available to Common Shareholders | |||||
| Loss per Common Share, Basic from continuing operations | |||||
| Loss per Common Share, Diluted from continuing operations | |||||
| Loss per Common Share, Basic from discontinued operations | |||||
| Loss per Common Share, Diluted from discontinued operations | |||||
| Loss per Common Share Basic | |||||
| Loss per Common Share Diluted | |||||
| Basic weighted average common shares outstanding | |||||
| Diluted weighted average of common shares outstanding | |||||
Loading...